Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit.


Journal

BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759

Informations de publication

Date de publication:
04 Mar 2020
Historique:
received: 02 11 2019
accepted: 20 02 2020
entrez: 6 3 2020
pubmed: 7 3 2020
medline: 30 10 2020
Statut: epublish

Résumé

Bovine respiratory disease (BRD) continues to be great challenge in calf rearing units. The urgent need to decrease the use of antibiotics and increase animal welfare in beef production has forced us to introduce new preventive methods. Vaccinations could contribute to the solution, but the high incidence of BRD already at an early age has made it difficult to introduce suitable vaccination programs. Challenge studies have shown promising results in 3-14 day old calves vaccinated with intranasal BRD vaccine, but very few field trials are available to assess the efficacy of the intranasal vaccines in field conditions. We evaluated the effect of one dose of commercial intranasal vaccination on calf mortality, daily gain, and treatment incidence for BRD in one calf rearing unit. In total, 497 calves (mean age 19 days) were included in our study, 247 of which were vaccinated at the time of arrival to the unit and 250 served as negative controls (unvaccinated). Vaccinated and unvaccinated calves were situated in separate compartments until weaning. Daily gain, treatment incidence, and mortality were recorded until the calves were transported to the finishing unit, which averaged 154.5 days from arrival. Average daily gain over the complete study period was 1151.9 g/day (SD 137.9) for the vaccinated calves and 1139.5 g/day (SD 135.9) for the unvaccinated calves. Intranasal vaccination combined with older arrival age (17 days or older) resulted in a higher daily gain (47.8 g/day) compared with unvaccinated calves (coef. 0.0478, p = 0.003). This association was not recorded in calves that were younger than 17 days upon arrival. Intranasal vaccination was not significantly associated either with mortality (OR 0.976, p = 0.968) or treatment incidence for BRD (OR 1.341, p = 0.120). In total, six vaccinated calves (2.43%) and six unvaccinated calves (2.40%) died during the study period. Vaccinating arriving calves with intranasal vaccine in the calf rearing unit did not decrease the mortality or treatment incidence for BRD, but it significantly improved the weight gain in calves transported to the unit at the age of 17 days or older.

Sections du résumé

BACKGROUND BACKGROUND
Bovine respiratory disease (BRD) continues to be great challenge in calf rearing units. The urgent need to decrease the use of antibiotics and increase animal welfare in beef production has forced us to introduce new preventive methods. Vaccinations could contribute to the solution, but the high incidence of BRD already at an early age has made it difficult to introduce suitable vaccination programs. Challenge studies have shown promising results in 3-14 day old calves vaccinated with intranasal BRD vaccine, but very few field trials are available to assess the efficacy of the intranasal vaccines in field conditions. We evaluated the effect of one dose of commercial intranasal vaccination on calf mortality, daily gain, and treatment incidence for BRD in one calf rearing unit. In total, 497 calves (mean age 19 days) were included in our study, 247 of which were vaccinated at the time of arrival to the unit and 250 served as negative controls (unvaccinated). Vaccinated and unvaccinated calves were situated in separate compartments until weaning. Daily gain, treatment incidence, and mortality were recorded until the calves were transported to the finishing unit, which averaged 154.5 days from arrival.
RESULTS RESULTS
Average daily gain over the complete study period was 1151.9 g/day (SD 137.9) for the vaccinated calves and 1139.5 g/day (SD 135.9) for the unvaccinated calves. Intranasal vaccination combined with older arrival age (17 days or older) resulted in a higher daily gain (47.8 g/day) compared with unvaccinated calves (coef. 0.0478, p = 0.003). This association was not recorded in calves that were younger than 17 days upon arrival. Intranasal vaccination was not significantly associated either with mortality (OR 0.976, p = 0.968) or treatment incidence for BRD (OR 1.341, p = 0.120). In total, six vaccinated calves (2.43%) and six unvaccinated calves (2.40%) died during the study period.
CONCLUSIONS CONCLUSIONS
Vaccinating arriving calves with intranasal vaccine in the calf rearing unit did not decrease the mortality or treatment incidence for BRD, but it significantly improved the weight gain in calves transported to the unit at the age of 17 days or older.

Identifiants

pubmed: 32131825
doi: 10.1186/s12917-020-02294-7
pii: 10.1186/s12917-020-02294-7
pmc: PMC7055024
doi:

Substances chimiques

Viral Vaccines 0

Types de publication

Journal Article Randomized Controlled Trial, Veterinary

Langues

eng

Sous-ensembles de citation

IM

Pagination

73

Subventions

Organisme : Maa- ja MetsätalousministeriÖ
ID : 2212/03.01.02/2015

Références

J Am Vet Med Assoc. 2012 May 15;240(10):1231-40
pubmed: 22559114
Vet Rec. 1999 Jul 10;145(2):33-9
pubmed: 10458574
Vet Immunol Immunopathol. 1989 Sep;22(2):145-60
pubmed: 2530685
PLoS One. 2016 Mar 17;11(3):e0150452
pubmed: 26986832
Vet J. 2007 Nov;174(3):627-35
pubmed: 17169592
Can J Vet Res. 1994 Jul;58(3):189-95
pubmed: 7954121
BMC Vet Res. 2013 Apr 15;9:79
pubmed: 23587206
Vet Microbiol. 2007 Jan 31;119(2-4):256-65
pubmed: 17084565
Vet Immunol Immunopathol. 2014 Apr 15;158(3-4):233-7
pubmed: 24534145
Vet J. 2008 May;176(2):177-81
pubmed: 17408994
PeerJ. 2014 Jan 02;2:e238
pubmed: 24482759
Vet Rec. 2013 Oct 5;173(13):319
pubmed: 23959049
Aust Vet J. 2007 Aug;85(8):311-6
pubmed: 17685976
Acta Vet Scand. 2004;45(3-4):193-200
pubmed: 15663079
Prev Vet Med. 2019 Jun 1;167:146-157
pubmed: 30948232
Comp Immunol Microbiol Infect Dis. 2007 May;30(3):143-51
pubmed: 17258318
J Dairy Sci. 2016 Dec;99(12):10174-10181
pubmed: 27720158
J Dairy Sci. 2018 Sep;101(9):8159-8168
pubmed: 29908805
J Am Vet Med Assoc. 2010 May 1;236(9):991-9
pubmed: 20433400
Prev Vet Med. 2018 Dec 1;161:100-108
pubmed: 30466650
Prev Vet Med. 2016 Apr 1;126:81-8
pubmed: 26879057
PLoS One. 2016 Jan 28;11(1):e0146488
pubmed: 26820134
Prev Vet Med. 2015 Jun 15;120(2):169-176
pubmed: 25937168
Vet J. 2009 Jan;179(1):101-8
pubmed: 17931918
Prev Vet Med. 2014 Feb 1;113(2):231-40
pubmed: 24269039
Can Vet J. 2014 Dec;55(12):1180-5
pubmed: 25477547
BMC Vet Res. 2012 Mar 14;8:26
pubmed: 22414223
J Anim Sci. 2006 Feb;84(2):488-98
pubmed: 16424278
J Am Vet Med Assoc. 2013 Dec 1;243(11):1602-8
pubmed: 24261811
PLoS One. 2013 Oct 21;8(10):e77525
pubmed: 24204857
Vet Rec. 2009 Aug 22;165(8):230-3
pubmed: 19700783
J Am Vet Med Assoc. 2007 Jan 15;230(2):233-43
pubmed: 17223757

Auteurs

Atte Sandelin (A)

Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Paroninkuja 20, 04920 Saarentaus, Helsinki, Finland. atte.sandelin@helsinki.fi.

Heidi Härtel (H)

HKScan Finland Oy, 50, 20521, Turku, PL, Finland.

Leena Seppä-Lassila (L)

Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Paroninkuja 20, 04920 Saarentaus, Helsinki, Finland.

Liisa Kaartinen (L)

Finnish Food Authority Ruokavirasto, Mustialankatu 3, 00790, Helsinki, Finland.

Helena Rautala (H)

Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Paroninkuja 20, 04920 Saarentaus, Helsinki, Finland.

Timo Soveri (T)

Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Paroninkuja 20, 04920 Saarentaus, Helsinki, Finland.

Heli Simojoki (H)

Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Paroninkuja 20, 04920 Saarentaus, Helsinki, Finland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH